Changes in MYCN expression in human neuroblastoma cell lines following cisplatin treatment may not be related to MYCN copy numbers

By                

Oncology Reports, Vol. 29, Iss. 6, 2013-01 ,pp. : 2415-2421

Spandidos Publications

Access to resources Recommend Favorite

Analysis of candidate gene co-amplification with MYCN in neuroblastoma

By George R.E.   Kenyon R.   McGuckin A.G.   Kohl N.   Kogner P.   Christiansen H.   Pearson A.D.J.   Lunec J.  

European Journal of Cancer, Vol. 33, Iss. 12, 1997-10 ,pp. : 2037-2042

Elsevier

Access to resources Recommend Favorite

Evidence that the MYCN oncogene regulates MRP gene expression in neuroblastoma

By Norris M.D.   Bordow S.B.   Haber P.S.   Marshall G.M.   Kavallaris M.   Madafiglio J.   Cohn S.L.   Salwen H.   Schmidt M.L.   Hipfner D.R.   Cole S.P.C.   Deeley R.G.   Haber M.  

European Journal of Cancer, Vol. 33, Iss. 12, 1997-10 ,pp. : 1911-1916

Elsevier

Access to resources Recommend Favorite

FAK inhibition decreases cell invasion, migration and metastasis in MYCN amplified neuroblastoma

By Megison Michael  

Clinical and Experimental Metastasis, Vol. 30, Iss. 5, 2013-06 ,pp. : 555-568

Springer Publishing Company

Access to resources Recommend Favorite

The Interaction Between FAK, MYCN, p53 and Mdm2 in Neuroblastoma

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 14, Iss. 1, 2014-01 ,pp. : 46-51

Bentham Science Publishers

Access to resources Recommend Favorite